Bioregenx BRGX
OTC BRGX
$0.01 +0.00 (+0.00%)
At close: Sep 21, 2026 · 4:00 PM EDT

Bioregenx (BRGX) Capital Expenditures (2024 - 2025)

Bioregenx (BRGX) posted Capital Expenditures of $3057.0 for Q4 2025, down 49.05% on a QoQ basis from $6000.0 in Q3 2025.

Analysis

Bioregenx (BRGX) Capital Expenditures (2024 - 2025) Analysis & Trends

Bioregenx has reported Capital Expenditures for 2 years, with the latest figure at $3057.0 in Q4 2025.

  • On a quarterly basis, Capital Expenditures changed N/A year-over-year to $3057.0 in Q4 2025; TTM through Dec 2025 was $9057.0, a 95.22% decrease from a year earlier, with the FY2025 full-year figure at $9057.0, down 95.22% from the prior year.
  • Capital Expenditures was $3057.0 for Q4 2025 at Bioregenx, down from $6000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $189390.0 in Q1 2024, with the low at $3057.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Abbott Laboratories 179.49 Bn 174.54 Bn 7.27 Bn 497.00 Mn
2 Intuitive Surgical 142.30 Bn 137.21 Bn 1.96 Bn 112.60 Mn
3 Medtronic 116.24 Bn 108.04 Bn 6.34 Bn 503.00 Mn
4 Stryker 105.51 Bn 102.03 Bn 4.50 Bn 202.00 Mn
5 Boston Scientific 65.13 Bn 64.83 Bn 3.85 Bn 195.00 Mn
6 Edwards Lifesciences 51.20 Bn 47.05 Bn 1.35 Bn 66.90 Mn
7 Dexcom 33.79 Bn 31.84 Bn 830.00 Mn 84.70 Mn
8 Resmed 32.01 Bn 30.54 Bn 861.22 Mn 51.13 Mn
9 Alcon 31.98 Bn 30.52 Bn 1.68 Bn -96.00 Mn
10 Bioregenx 9.72 Mn 9.67 Mn 348,288.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3,057.00
Sep 30, 2025 6,000.00
Mar 31, 2024 189,390.00
API Access

Bioregenx Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BRGX&period=max&api_key=YOUR_API_KEY